Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice

详细信息	查看全文 | 推荐本文 |

• 作者：Teresa C.M. Garcia ; Cristina T. Fonseca ; Lucila G.G. Pacifico ; Fern ; a do Valle Durã ; es ; Fá ; bio Ant&#xf4 ; nio Vitarelli Marinho ; Marcos L.O. Penido ; Marcelo V. Caliari ; Alan L. de Melo ; Hudson A
• 关键词：Peptide ; Vaccine ; Schistosoma mansoni
• 刊名：Acta Tropica
• 出版年：2008
• 期刊代码：2_0001706x
• 类别：imm
• 出版时间：June 2008
• 卷：106
• 期：3
• 页码：162-167
• 文件大小：492 K

摘要

Sm14 and paramyosin are two major Schistosoma mansoni vaccine candidate antigens. Recently, we have identified Sm14 and paramyosin epitopes that are recognized by T cells of resistant individuals living in endemic areas for schistosomiasis. Herein, mice were immunized with these peptides separately or in association in order to evaluate their vaccine potential. Immunization of mice with Sm14 peptides alone or mixed with paramyosin peptides was able to induce 26%–36.7%or 28%–29.2%of worm burden reduction, 67%or 46%of intestinal eggs reduction and also 54%–61%or 43%–52%of liver pathology reduction, respectively. Protection was associated with a Th1 type of immune response induced by Sm14 peptide immunization. In contrast, paramyosin peptide vaccination did not engender protective immunity or liver pathology reduction and immunization was associated with a Th2 type of immune response.